TuesdayApr 29, 2025 1:45 pm

QualityStocksNewsBreaks – Better Choice Company, Inc. (NYSE American: BTTR) Completes Merger with SRx Health, Will Rebrand as SRx Health Solutions Inc.

Better Choice Company (NYSE American: BTTR) announced the closing of its business combination with SRx Health Solutions, Inc., along with an $8.8 million private placement involving 4,036,697 shares of common stock and pre-funded warrants priced at $2.18 per share. As part of the merger, Better Choice will issue 28.6 million shares and rebrand as “SRx Health Solutions Inc.” with a new ticker symbol, “SRXH,” effective Apr. 30, 2025. The combined company aims to become a global health and wellness leader focused on solutions for pets, people and families. To view the full press release, visit https://ibn.fm/OWpWX About Better Choice Company…

Continue Reading

TuesdayApr 29, 2025 12:31 pm

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Moves Forward to Strengthen the Case for HyBryte(TM)

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, is advancing its phase 3 replication study (“FLASH2”) for HyBryte(TM), a novel photodynamic therapy designed to treat early-stage cutaneous T-cell lymphoma (“CTCL”). Building on the success of a prior phase 3 trial, HyBryte(TM)—which uses synthetic hypericin activated by safe visible light—offers a potentially game-changing approach by providing a noninvasive, well-tolerated alternative that targets malignant T-cells with precision. With patient enrollment underway and interim analysis expected in early 2026, the study is designed to potentially meet the stringent requirements of regulatory agencies in order to strengthen the case for HyBryte(TM) as a commercially available…

Continue Reading

TuesdayApr 29, 2025 11:22 am

QualityStocksNewsBreaks – Adageis Is Reshaping Patient Care Through Smart Tech

Adageis is revolutionizing healthcare with its flexible, AI-centric software solutions and ProActive Care Platform, built to eliminate administrative burdens and enable providers to focus on patients. With simplicity core to its design, the platform empowers healthcare organizations by identifying missed revenue opportunities from insurers and guiding providers to secure rightful payments. Using predictive analytics through its Patented Risk Engine (“PRE”), Adageis enhances steady cash flow by forecasting incentive payments and factoring receivables. The platform seamlessly integrates with over 90 electronic health record systems, minimizing disruption and easing the shift to value-based care. As the healthcare sector continues in this trend, Adageis…

Continue Reading

TuesdayApr 29, 2025 10:46 am

QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Expands International Reach with Juve Stabia Matches on Destination Calcio TV 

Brera Holdings (NASDAQ: BREA) announced that its Italian Serie B squad, S.S. Juve Stabia, will have its next two fixtures streamed live and free in the United States, Canada and United Kingdom via Destination Calcio TV. The matches—against Catanzaro on May 1 and Brescia on May 4—will feature full English commentary and be accessible through the Destination Calcio app and website. Brera Holdings emphasized that expanding Juve Stabia’s global presence aligns with its multi-club ownership strategy and the growing internationalization of football media rights.  To view the full press release, visit https://ibn.fm/KahxW  About Brera Holdings PLC  Brera Holdings PLC is…

Continue Reading

TuesdayApr 29, 2025 9:40 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Reports Positive VALID-ECG Study Results Supporting 12-Lead ECG Technology

HeartBeam (NASDAQ: BEAT) announced that its synthesized 12-lead ECG technology met clinical endpoints in the VALID-ECG pivotal study, achieving a 93.4% diagnostic agreement with standard 12-lead ECGs for arrhythmia assessment. Results were presented by Dr. Thomas Deering of Piedmont Heart Institute during the Heart Rhythm Society’s annual conference. HeartBeam’s 3D ECG technology, designed to fit into a credit card-sized device, aims to bring hospital-grade cardiac insights to patients anywhere, with commercialization planned following anticipated FDA clearance. To view the full press release, visit https://ibn.fm/ABvdX About HeartBeam Inc. HeartBeam is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac…

Continue Reading

TuesdayApr 29, 2025 9:10 am

QualityStocksNewsBreaks – NextPlat Corp (NASDAQ: NXPL) Receives Nasdaq Notice for Minimum Bid Price Noncompliance

NextPlat (NASDAQ: NXPL, NXPLW) announced it has received a written notice from Nasdaq Stock Market LLC stating that the company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as its closing bid price has remained below $1.00 per share for 30 consecutive business days. NextPlat has been granted a 180-calendar day period, until Oct. 27, 2025, to regain compliance by maintaining a minimum $1.00 closing bid price for at least 10 consecutive business days. The company may qualify for an additional 180-day extension if it meets other listing requirements. NextPlat stated it is actively pursuing strategies to improve business efficiency…

Continue Reading

TuesdayApr 29, 2025 9:00 am

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Launches Newton Fast Motion Shaft for Enhanced Swing Speed and Control

Newton Golf Company (NASDAQ: NWTG) announced the launch of its newest shaft family, Newton Fast Motion, now available for purchase at a suggested retail price of $325. The lighter, Tour-proven shaft is engineered to deliver exceptional precision and enhanced swing speed, building on the company’s four core technologies: Elongated Bend Profile, Kinetic Energy Storage, Symmetry 360 Construction and Variable Bend Profile. The Fast Motion series, constructed with advanced high-modulus Toray carbon fibers and featuring a distinctive red-to-gold finish, has already seen adoption by more than 30 professionals across the PGA TOUR Champions and LPGA Tour. Following 887% revenue growth in FY2024,…

Continue Reading

MondayApr 28, 2025 1:25 pm

QualityStocksNewsBreaks – AirJoule Technologies Corporation (NASDAQ: AIRJ) Secures $15 Million Private Placement Led by GE Vernova

AirJoule Technologies (NASDAQ: AIRJ) announced it has entered into subscription agreements for a $15 million private placement anchored by GE Vernova and other investors to accelerate commercialization of its AirJoule® system, which extracts pure water from air using low-grade waste heat. The net proceeds will fund pilot deployments of the AirJoule® A1000™ units in 2025. AirJoule and GE Vernova also launched a strategic project to integrate the technology into GE Vernova’s product offerings for industrial water production. To view the full article, visit https://ibn.fm/1lPuw About AirJoule Technologies Corporation AirJoule Technologies Corporation (NASDAQ: AIRJ) (formerly Montana Technologies Corporation) is the developer…

Continue Reading

MondayApr 28, 2025 10:15 am

QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXZ) (TSX: BCT) Prices $13.8 Million Public Offering

BriaCell Therapeutics (Nasdaq: BCTX, BCTXZ) (TSX: BCT) announced the pricing of an underwritten public offering of 3,066,666 units at $4.50 per unit for gross proceeds of approximately $13.8 million. Each unit includes one common share or pre-funded warrant and one warrant exercisable at $5.25 per share. The offering, led by ThinkEquity, is expected to close on April 28, 2025, subject to customary conditions. BriaCell plans to use the net proceeds for working capital, corporate purposes and advancing business objectives. To view the full article, visit https://ibn.fm/YUyxu About BriaCell Therapeutics BriaCell is a clinical-stage biotechnology company that develops novel immunotherapies to…

Continue Reading

FridayApr 25, 2025 3:59 pm

QualityStocksNewsBreaks – Why Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’ 

Nutriband (NASDAQ: NTRB), a company focused on the development of a portfolio of transdermal pharmaceutical products, was featured in a recent article that discussed its innovative AVERSA(TM) abuse-deterrent technology and business model. “AVERSA technology has the potential to improve the safety profile of transdermal drugs susceptible to abuse, such as fentanyl, while making sure that these drugs remain accessible to patients who need them. The technology is covered by a broad intellectual property portfolio with patents granted in the United States, Europe, Japan, Korea, Russia, Canada, Mexico, Australia, and China, with recent extensions into Macao,” the article reads.  “The company’s…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered